Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Varadhan

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
Transplantation and Cellular Therapy|July 22, 2021
Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary Central Nervous System LymphomaCole H Sterling, Hua-Ling Tsai, Matthias Holdhoff, et al.
Leukemia Research|September 5, 2017
Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literatureKelly J Norsworthy, Amy E DeZern, Hua-Ling Tsai, et al.
Research Square|March 30, 2023
Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American CollaborationTania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2020
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease ProphylaxisPhilip H Imus, Hua-Ling Tsai, Amy E DeZern, et al.
Journal of the American Geriatrics Society|April 20, 2017
Integrating Frailty Research into the Medical Specialties-Report from a U13 ConferenceJeremy Walston, Thomas N Robinson, Susan Zieman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2018
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not OutcomesShannon R McCurdy, Stephen T Muth, Hua-Ling Tsai, et al.
Annals of Internal Medicine|July 5, 2021
Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort StudySophie Lanzkron, Jane Little, Hang Wang, et al.
Transplantation and Cellular Therapy|December 22, 2022
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft SourceCole H Sterling, Michael S Hughes, Hua-Ling Tsai, et al.
Leukemia & Lymphoma|August 2, 2022
Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective studyMichael S Hughes, Cole H Sterling, Ravi Varadhan, et al.
Haematologica|July 6, 2023
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaborationTania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Transplantation and Cellular Therapy|July 22, 2021
Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary Central Nervous System LymphomaCole H Sterling, Hua-Ling Tsai, Matthias Holdhoff, et al.
Leukemia Research|September 5, 2017
Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literatureKelly J Norsworthy, Amy E DeZern, Hua-Ling Tsai, et al.
Research Square|March 30, 2023
Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American CollaborationTania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2020
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease ProphylaxisPhilip H Imus, Hua-Ling Tsai, Amy E DeZern, et al.
Journal of the American Geriatrics Society|April 20, 2017
Integrating Frailty Research into the Medical Specialties-Report from a U13 ConferenceJeremy Walston, Thomas N Robinson, Susan Zieman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2018
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not OutcomesShannon R McCurdy, Stephen T Muth, Hua-Ling Tsai, et al.
Annals of Internal Medicine|July 5, 2021
Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort StudySophie Lanzkron, Jane Little, Hang Wang, et al.
Transplantation and Cellular Therapy|December 22, 2022
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft SourceCole H Sterling, Michael S Hughes, Hua-Ling Tsai, et al.
Leukemia & Lymphoma|August 2, 2022
Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective studyMichael S Hughes, Cole H Sterling, Ravi Varadhan, et al.
Haematologica|July 6, 2023
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaborationTania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Pageof 18